Dimensional Fund Advisors’s F-star Therapeutics, Inc. Common Stock FSTX Stock Holding History

Dimensional Fund Advisors’s Portfolio FSTX Stock Details FSTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-39,184	Closed	-$337K	–	3549
2021 Q2	$337K	Buy	+39,184	New	+$334K	﹤0.01%	3241
2020 Q2	–	Sell	-6,553	Closed	-$24K	–	3368
2020 Q1	$24K	Buy	6,553 +1,221	+23%	+$6.32K	﹤0.01%	3348
2019 Q4	$34K	Buy	5,332 +365	+7%	+$4.64K	﹤0.01%	3360
2019 Q3	$70K	Hold	4,967	–	–	﹤0.01%	3369
2019 Q2	$73K	Hold	4,967	–	–	﹤0.01%	3415
2019 Q1	$208K	Hold	4,967	–	–	﹤0.01%	3303
2018 Q4	$206K	Buy	+4,967	New	+$223K	﹤0.01%	3283

Other funds holding FSTX

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

AVA

Atlas Venture Advisors Boston, Massachusetts $143M AUM 25.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors's FSTX Position: Q3 2021 in Review

Dimensional Fund Advisors sold out of F-star Therapeutics, Inc. Common Stock (FSTX) in Q3 2021, closing a stake of 39,184 shares — an estimated $337K sold.

Dimensional Fund Advisors first reported a position in FSTX in Q4 2018 and held it in 7 quarters. The position peaked at $337K in Q2 2021. 37 funds tracked by Wall St. Rank hold FSTX as of Q3 2021.

Dimensional Fund Advisors reported no remaining F-star Therapeutics, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
Dimensional Fund Advisors sold 39,184 F-star Therapeutics, Inc. Common Stock shares in Q3 2021, an estimated $337K.
Dimensional Fund Advisors first reported a position in F-star Therapeutics, Inc. Common Stock in Q4 2018 and held it in 7 quarters.
Dimensional Fund Advisors's F-star Therapeutics, Inc. Common Stock position peaked at $337K in Q2 2021.
37 funds tracked by Wall St. Rank held F-star Therapeutics, Inc. Common Stock as of Q3 2021.

Based on Dimensional Fund Advisors's 13F filing for Q3 2021, filed 12 Nov 2021.